Nutu™ Digital Health Platform for Obesity
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new digital health tool called Nutu™ to determine its effectiveness in assisting people with obesity when added to their regular care program. The study compares two groups: one receives standard care, including nutrition counseling and doctor visits, while the other receives the same care plus access to the Nutu™ platform. The goal is to assess whether the Nutu™ platform enhances the effectiveness and acceptability of obesity treatment. Participants already in the FLOW clinical program for obesity may be well-suited for this trial. As an unphased trial, this study provides a unique opportunity to explore innovative solutions for obesity management.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the Nutu™ digital health platform is safe for use in obesity treatment?
In a previous study, researchers examined the acceptance of the Nutu™ digital health platform as part of a weight loss program. The study reported no serious safety issues and focused on user engagement, finding it a helpful tool for managing obesity.
As a digital health platform, Nutu™ does not involve medication or medical procedures, making it generally low-risk compared to drug or surgical treatments. However, like many digital tools, concerns about data privacy and long-term user engagement may arise.
Overall, evidence suggests that Nutu™ is a safe option for weight management, with no major negative effects reported in the available studies.12345Why are researchers excited about this trial?
Researchers are excited about the Nutu™ digital health platform for obesity because it offers a unique, tech-driven approach to weight management. Unlike traditional options such as diet plans, exercise, and medication, Nutu™ integrates digital tools to support lifestyle changes. This platform provides personalized guidance and real-time tracking, making it easier and more engaging for users to stick to their health goals. By combining standard care with innovative technology, Nutu™ has the potential to enhance long-term success in managing obesity.
What evidence suggests that the Nutu™ digital health platform is effective for obesity?
Research shows that digital health tools like Nutu™ can help people manage their weight by encouraging healthy habits. One study found that weight loss apps, which often include coaching and feedback, work better when combined with other treatments. In this trial, participants in the FLOW + Nutu™ Offer arm will receive standard FLOW care and can access the Nutu™ digital health platform. In a 6-month study, people using a digital health app for obesity lost a significant amount of weight. These tools help users track their progress and stay motivated. Nutu™ aims to offer similar benefits as part of primary care programs for managing obesity.12367
Who Is on the Research Team?
Drew Sayer, PhD
Principal Investigator
University of Alabama at Birmingham
Are You a Good Fit for This Trial?
This trial is for patients already enrolled in the FLOW clinical program at UAB, focusing on those who need help managing childhood or adult obesity and related cardiovascular risks.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the standard 12-month FLOW program, with or without the Nutu™ digital health platform
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Nutu™
Trial Overview
The study tests how well adding the Nutu™ digital health platform to regular obesity treatment works. It's a Zelen randomized controlled trial, meaning some people will get this new tool while others won't, by chance.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants receive standard FLOW care and are offered access to the Nutu™ digital health platform, which may be accepted or declined.
Participants receive the standard 12-month FLOW program including nutrition counseling, physician visits, and behavioral health support.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
Willow Laboratories, Inc.
Collaborator
Citations
Retrospective Cohort Study of a Digital Weight Loss Service
Digital platforms offering coaching, self-monitoring, and automated feedback have the potential to further augment pharmacological efficacy.
Augmenting Primary Care-Based Obesity Management ...
This study evaluates the acceptability and clinical effectiveness of integrating the Nutu™ digital health platform into a comprehensive primary ...
3.
ctv.veeva.com
ctv.veeva.com/study/augmenting-primary-care-based-obesity-management-with-the-nutu-digital-health-platformAugmenting Primary Care-Based Obesity Management With ...
This study evaluates the acceptability and clinical effectiveness of integrating the Nutu™ digital health platform into a comprehensive ...
4.
pubmed.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov/41408456/?utm_source=FeedFetcher&utm_medium=rss&utm_campaign=None&utm_content=1Jgu41lFGSj_ShZE4NRQ2hnLFGqOVFuKpoCzfmgi2UmEsRik-&fc=None&ff=20251218082326&v=2.18.0.post22+67771e26-months results from a randomized controlled trial
Efficacy of a digital health application for weight management in people with obesity: 6-months results from a randomized controlled trial.
Can Digital Technologies Be Useful for Weight Loss in ...
This review aimed to assess the effectiveness of digital resources in supporting behavior changes, and thus influencing weight loss, in people with overweight ...
Integrating digital health into pediatric obesity management
Despite these advancements, DHIs still face major challenges, including unequal access, data privacy concerns, and a lack of long-term outcome evaluations.
7.
linkedin.com
linkedin.com/posts/ongoingnow_semaglutide-safety-understanding-rare-optic-activity-7426734605698908160-5DHBSemaglutide Safety Update: Rare Optic Nerve Risks Clarified
Their digital health platform, Nutu, delivers personalized, CDC-aligned diabetes prevention programming with AI-powered coaching, expanding ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.